Rucaparib: observed
5 studies: patients on it are followed, or it is given outside a trial. Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO StudyCompletedNCT04539327Results postedReport a problem
- A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated PatientsCompletedNCT07477756Report a problem
- Pancytopenia Related to PARP Inhibitors (PancytoRIB)CompletedNCT04774627Report a problem
- Arterial Hypertension Related to PARP Inhibitors (ArteRIB)CompletedNCT04774406Report a problem
- Myelodysplastic Syndrome and Acute Myeloid Leukemia Related to PARP Inhibitors (MyeloRIB)CompletedNCT04326023Report a problem